Oncology

Benevet Oncology will adapt Privo Technologies’ platforms to advance cancer treatments for animals

The innovation also has the potential to detect other diseases in livestock, in addition to detecting up to 200 types of cancers

ELIAS Cancer Immunotherapy is an adoptive cell therapy treatment for canine osteosarcoma

Philip Bergman, DVM, MS, PhD, DACVIM (Oncology), kicked off the 2025 Fetch Charlotte conference with his keynote address on key innovations in veterinary oncology

Rachel Venable, DVM, MS, DACVIM (Oncology) discussed what primary doctors can do to treat their patients with cancer when clients decline specialty care during a WVC 2025 CE session

Lovey presented to the clinic lethargic, with inappetence but consuming plenty of water, and a bulge on her abdomen when lying down

The type of lesion will guide treatment and prognosis

Most major sections of the new animal drug application for Laverdia-CA1 have been deemed complete by the FDA, bringing the drug closer to approval

AI Masses is an addition to Zoetis’ Vetscan Imagyst platform

Vetigenics is seeing encouraging results of a completed study for an antibody aimed at treating oral melanoma in dogs, used in combination with palliative radition.

Over the next 3 years, IDEXX Cancer Dx will expand to include most canine cancer cases

Integrative therapies can enhance a patient’s survival and quality of life

dvm360 is counting down the Top 20 news stories and articles from 2024 with this series of spotlights.

Philip Bergman, DVM, PhD, MS, DACVIM (Oncology), talks about compounded CCNU, as well as the precision of 503B outsourcing facilities

Canalevia-CA1 is currently the only treatment on the market for treating CID in canine patients.

Ann Hohenhaus, DVM, DACVIM (Oncology, SAIM), delved into essential components of a diagnostic investigation of dogs with MCRs, including fine-needle aspiration and diagnostic imaging methods during her session at the NY Vet Show in New York, New York

A team at Texas A&M University is using pig skin cells to explore the use of photodynamic therapy to treat melanoma in humans and animals

Calviri recently announced the initiation of new vaccine trial that targets early-stage hemangiosarcoma tumors in canines

Rachel Allbaugh, DVM, MS, DACVO, explains her squamous cell carcinoma diagnosis procedure, beyond just the clinical signs

The technological innovation is an expansion of the NOBIVAC NXT platform, and a breakthrough achievement against one of the most common feline diseases

CureLab Veterinary Inc is conducting a Regulation D fundraising offering for its gene therapy, ElenaVet

New research has uncovered gene responsible for graying speeds in horses, and a predisposition to melanoma

A BluePearl hospital in Malvern, Pennsylvania, is the first veterinary hospital to utilize this technology

FidoCure used AI technology to aid in the development of the new oncology drug

What can general practitioners do in a primary care setting?

A new study showed that this cell-sizing method is useful for characterizing feline lymphoma and predicting patient survival time

Recognizing PNS can help veterinarians identify neoplasia earlier and improve the quality of life in patients with cancer

Craig A Clifford DVM, MS, DACVIM (Oncology), gives an inside look into his upcoming Fetch Kansas City lecture on canine lymphoma

ELIAS Animal health will combine its adoptive T cell therapy with a new adjuvant in an upcoming study

Researchers within the United States are investigating risk factors for osteosarcoma in canine and human patients